JWH-133 also suppresses key pathways linked to cancer progression, such as cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) production, while inhibiting Cdc42 and decreasing the nuclear expression of c-Fos and c-Jun. Here, PTGS2 is linked to cancer.